After 30 years in the aesthetic space, I’ve seen the industry evolve dramatically, but the current wave of consolidation and financial pressure feels unprecedented.
In this brief video, I break down key insights from Michael Moretti’s hard-hitting article “Aesthetic Industry Experiences Traumatic Consolidation” and compare them with trends I’ve observed firsthand.
From declining sales of flagship products like Botox and Juvederm, to falling profit margins, clinic bankruptcies, and even major device manufacturers exiting the stock market — it’s clear the industry is going through a major correction.
But it’s not all doom and gloom. This shakeout may lead to a more sustainable and resilient aesthetic landscape for those prepared.
In this brief video, I break down key insights from Michael Moretti’s hard-hitting article “Aesthetic Industry Experiences Traumatic Consolidation” and compare them with trends I’ve observed firsthand.
From declining sales of flagship products like Botox and Juvederm, to falling profit margins, clinic bankruptcies, and even major device manufacturers exiting the stock market — it’s clear the industry is going through a major correction.
But it’s not all doom and gloom. This shakeout may lead to a more sustainable and resilient aesthetic landscape for those prepared.
If you want more clarity on your own numbers, check out my short, practical online course to help you get full control of your clinic finances and strategy: ronmyers.co.uk
